Both cardiologists and patients grapple with the concept that fixing a blockage may not prolong life, as indicated by the results of the landmark COURAGE and BARI 2D trials and reflected by the limited effect these trials seem to have had on clinical practice.
The large ISCHEMIA trial, led by Dr Judith Hochman, seeks to build on the results of COURAGE and BARI 2D to answer the important question: what is the best treatment for patients with stable coronary disease?
Dr Hochman joins the show to discuss rationale and trial design and give information on how to become involved in the study.
For more information on ISCHEMIA, click here.
To contact the study organizers, click here.
Dr Hochman has no relevant financial disclosures.
For Dr Harrington's disclosures, click here.
Huge ISCHEMIA trial to tackle unanswered COURAGE, BARI 2D questions
Physicians still doing late PCI of occluded arteries in stable patients
Medical therapy takes COURAGE: No benefit of PCI over optimal drugs for preventing events in stable CAD
No mortality, CV-event differences between revascularization and medical therapy in diabetics: BARI 2D
Cite this: #41: The ISCHEMIA trial on optimal care for patients with stable coronary disease with Dr Judith Hochman - Medscape - Oct 06, 2011.